Technical Analysis for CDNA - CareDx, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 7.56 | 0.00% | 0.00 |
Earnings due: May 8
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -5.26% | |
| Oversold Stochastic | Weakness | -5.26% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 15 hours ago |
| Outside Day | about 15 hours ago |
| Up 3% | about 15 hours ago |
| Fell Below Previous Day's Low | about 16 hours ago |
| Down 1% | about 16 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/08/2024
CareDx, Inc. Description
CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine In Vitro Gene Expression Blood Test Transplantation Medicine Organ Transplantation Transplant Rejection
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.91 |
| 52 Week Low | 4.8 |
| Average Volume | 795,581 |
| 200-Day Moving Average | 9.09 |
| 50-Day Moving Average | 9.57 |
| 20-Day Moving Average | 8.82 |
| 10-Day Moving Average | 8.02 |
| Average True Range | 0.54 |
| RSI (14) | 31.97 |
| ADX | 15.33 |
| +DI | 18.60 |
| -DI | 28.44 |
| Chandelier Exit (Long, 3 ATRs) | 9.47 |
| Chandelier Exit (Short, 3 ATRs) | 9.05 |
| Upper Bollinger Bands | 10.60 |
| Lower Bollinger Band | 7.04 |
| Percent B (%b) | 0.15 |
| BandWidth | 40.42 |
| MACD Line | -0.59 |
| MACD Signal Line | -0.49 |
| MACD Histogram | -0.101 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.19 | ||||
| Resistance 3 (R3) | 8.21 | 8.03 | 8.09 | ||
| Resistance 2 (R2) | 8.03 | 7.87 | 8.02 | 8.05 | |
| Resistance 1 (R1) | 7.79 | 7.77 | 7.70 | 7.77 | 8.01 |
| Pivot Point | 7.61 | 7.61 | 7.56 | 7.60 | 7.61 |
| Support 1 (S1) | 7.37 | 7.45 | 7.28 | 7.35 | 7.11 |
| Support 2 (S2) | 7.19 | 7.35 | 7.18 | 7.07 | |
| Support 3 (S3) | 6.95 | 7.19 | 7.04 | ||
| Support 4 (S4) | 6.93 |
